Commerzbank Aktiengesellschaft FI Has $201,000 Stake in Cardinal Health, Inc. $CAH

Commerzbank Aktiengesellschaft FI lessened its holdings in shares of Cardinal Health, Inc. (NYSE:CAH) by 92.6% during the 2nd quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 1,196 shares of the company’s stock after selling 14,859 shares during the quarter. Commerzbank Aktiengesellschaft FI’s holdings in Cardinal Health were worth $201,000 at the end of the most recent reporting period.

Several other large investors also recently added to or reduced their stakes in CAH. Greykasell Wealth Strategies Inc. acquired a new stake in shares of Cardinal Health in the 1st quarter valued at $26,000. Jones Financial Companies Lllp lifted its position in shares of Cardinal Health by 198.3% in the first quarter. Jones Financial Companies Lllp now owns 21,112 shares of the company’s stock worth $27,000 after buying an additional 14,034 shares during the last quarter. GW&K Investment Management LLC boosted its stake in shares of Cardinal Health by 113.4% during the 1st quarter. GW&K Investment Management LLC now owns 271 shares of the company’s stock worth $37,000 after acquiring an additional 144 shares in the last quarter. Garde Capital Inc. acquired a new position in shares of Cardinal Health during the 1st quarter valued at about $52,000. Finally, Zions Bancorporation National Association UT bought a new position in shares of Cardinal Health in the 1st quarter valued at approximately $52,000. 87.17% of the stock is owned by institutional investors.

Cardinal Health Stock Performance

NYSE CAH opened at $156.86 on Friday. Cardinal Health, Inc. has a twelve month low of $106.98 and a twelve month high of $168.44. The stock has a market cap of $37.27 billion, a PE ratio of 24.32, a PEG ratio of 1.33 and a beta of 0.71. The firm has a 50-day simple moving average of $152.09 and a 200 day simple moving average of $151.21.

Cardinal Health (NYSE:CAH) last announced its quarterly earnings data on Tuesday, August 12th. The company reported $2.08 EPS for the quarter, topping analysts’ consensus estimates of $2.03 by $0.05. The company had revenue of $60.16 billion during the quarter, compared to the consensus estimate of $60.91 billion. Cardinal Health had a negative return on equity of 74.45% and a net margin of 0.70%.The company’s quarterly revenue was up .5% on a year-over-year basis. During the same quarter last year, the company earned $1.84 EPS. Cardinal Health has set its FY 2026 guidance at 9.300-9.500 EPS. Research analysts forecast that Cardinal Health, Inc. will post 7.95 earnings per share for the current fiscal year.

Cardinal Health Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Wednesday, October 15th. Shareholders of record on Wednesday, October 1st will be issued a $0.5107 dividend. This represents a $2.04 annualized dividend and a yield of 1.3%. The ex-dividend date of this dividend is Wednesday, October 1st. Cardinal Health’s payout ratio is 31.63%.

Analyst Upgrades and Downgrades

CAH has been the subject of a number of recent analyst reports. Wells Fargo & Company reaffirmed an “overweight” rating and set a $185.00 target price (up previously from $183.00) on shares of Cardinal Health in a research report on Wednesday, August 13th. Robert W. Baird raised their target price on shares of Cardinal Health from $197.00 to $203.00 and gave the company an “outperform” rating in a research note on Wednesday, August 13th. Morgan Stanley reiterated an “overweight” rating on shares of Cardinal Health in a report on Tuesday, August 12th. UBS Group restated a “buy” rating on shares of Cardinal Health in a report on Tuesday, August 12th. Finally, Wall Street Zen lowered Cardinal Health from a “strong-buy” rating to a “buy” rating in a research note on Saturday, August 2nd. Twelve research analysts have rated the stock with a Buy rating and three have given a Hold rating to the company. According to data from MarketBeat.com, Cardinal Health has an average rating of “Moderate Buy” and a consensus target price of $166.00.

Insider Buying and Selling

In other Cardinal Health news, CEO Jason M. Hollar sold 107,705 shares of the firm’s stock in a transaction dated Tuesday, August 19th. The shares were sold at an average price of $148.90, for a total transaction of $16,037,274.50. Following the completion of the transaction, the chief executive officer owned 235,901 shares in the company, valued at $35,125,658.90. This trade represents a 31.35% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, insider Ola M. Snow sold 28,151 shares of Cardinal Health stock in a transaction that occurred on Tuesday, August 19th. The shares were sold at an average price of $148.94, for a total value of $4,192,809.94. Following the sale, the insider directly owned 15,431 shares in the company, valued at $2,298,293.14. The trade was a 64.59% decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last quarter, insiders have sold 271,676 shares of company stock worth $40,489,525. Insiders own 0.12% of the company’s stock.

About Cardinal Health

Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.